The Effect of Consumption of Kiwifruit on Constipation in Adults

NCT02215785 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2014-08-13

No results posted yet for this study

Summary

Constipation is a symptom suffered by a large number of people, due to multifactorial causes. Some studies have proven that modifying lifestyle reduces the risk of constipation, with high-fibre diets being less prone to constipation. Kiwifruit consumption, improves functional constipation and some studies consistently report an increase in the frequency and ease of defecation, stool volume and softness.

Although literature suggests kiwifruit consumption improves constipation symptoms, no studies have been carried out in adults and in Mediterranean patient populations, characteristic for its differential nutritional habits. The aim of the present study was to test the effect of kiwifruit consumption on functional constipation in a Spanish adult population.

Conditions

Interventions

OTHER

Kiwifruit

Throughout the five-week study period the patient had to continue their normal eating habits and exercise regime.

Sponsors & Collaborators

  • Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

    lead OTHER

Principal Investigators

  • Marta Besa Castellà, Dr · Catalan Institute of Health (ICS)

  • Francisco Berlanga López · Catalan Institute of Health (ICS)

  • Caterina Calvet Torres, Dr · Catalan Institut of Health (ICS)

  • M Àngeles Cisneros Antó · Catalan Institut of Health (ICS)

  • Judith Company Fontané · Catalan Institut of Health (ICS)

  • Rosa Ma Clofent Vilaplana, Dr and Ph.D · Catalan Institut of Health (ICS)

  • Caridad Delgado López, Dr · Catalan Institu of Health (ICS)

  • Ma Isabel Denche Naranjo · Catalan Institut of Health (ICS)

  • Maite Escudero Ruiz · Catalan Institut of Health (ICS)

  • Angela Ferreres Castell · Catalan Institut of Health (ICS)

  • Sonia Fuentes Rodriguez, Dr · Catalan Institut of Health (ICS)

  • Amparo Gallart Iglesias · Catalan Institut of Health (ICS)

  • M Roser Garriga Bacardí, Dr · Catalan Institut of Health (ICS)

  • Isabel Marin Quilez · Catalan Institut of Health (ICS)

  • Mercè Marzo Castillejo,, Dr and Ph.D · Catalan Institut of Health (ICS) and IDIAP Jordi Gol

  • Juanjo Mascort Roca, Dr · Catalan Institut of Health (ICS)

  • Maria Ollé Mitjans, Dr · Catalan Institut of Health (ICS)

  • Vanesa Pérez Martín · Catalan Institut of Health (ICS)

  • Francesca Peñas López, Dr · Catalan Institut of Health (ICS)

  • Gemma Nerin Pueyo · Catalan Institut of Health (ICS)

  • Rosa Ramírez Torralbo, Dr · Catalan Institut of Health (ICS)

  • Mercedes Rodriguez Pascual · Catalan Institut of Health (ICS)

  • Laura Ruipérez Martín · Catalan Institut of Health (ICS)

  • Josefa Ruiz Tejero · Catalan Institut of Health (ICS)

  • Sonia Varela Folgueiras · Catalan Institut of Health (ICS)

  • Carmen Vela Vallespín, Dr · Catalan Institut of Health (ICS)

  • Mercè Vilarrubi Estrella, Dr · Catalan Institut of Health (ICS)

  • Ivan Villar Balboa, Dr · Catalan Institut of Health (ICS)

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2013-08-31
Completion
2013-10-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02215785 on ClinicalTrials.gov